Global Autoimmune Disease Treatment Device Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Autoimmune Disease Treatment Device market size was valued at US$ 10551 million in 2025 and is forecast to a readjusted size of US$ 15806 million by 2032 with a CAGR of 6.1% during review period.
Autoimmune Disease Treatment Device refers to a category of medical devices designed to diagnose, manage, modulate, or therapeutically treat autoimmune disorders by regulating immune system activity, removing pathogenic substances from blood, delivering targeted stimulation, supporting biologic administration, or monitoring disease progression. These devices are used in the treatment of autoimmune conditions such as rheumatoid arthritis, lupus, multiple sclerosis, inflammatory bowel disease, psoriasis, myasthenia gravis, and type 1 diabetes. Autoimmune Disease Treatment Devices include plasmapheresis systems, immunoadsorption equipment, infusion pumps, neurostimulation devices, wearable monitoring systems, photopheresis systems, and targeted therapeutic delivery technologies that help improve disease management, reduce inflammatory activity, and enhance patient quality of life.
The Autoimmune Disease Treatment Device industry chain starts upstream with suppliers of medical-grade polymers, semiconductors, biosensors, filtration membranes, catheters, electronic components, biologic-compatible materials, and precision software systems, continues midstream through medical device manufacturers conducting product design, clinical testing, regulatory approval, intelligent system integration, assembly, sterilization, and distribution, and extends downstream to hospitals, specialty clinics, dialysis centers, research institutes, ambulatory care facilities, and homecare providers where devices are used for immune modulation, blood purification, biologic administration, disease monitoring, and long-term autoimmune disorder management, while service providers support maintenance, software upgrades, physician training, and post-treatment patient monitoring across global healthcare systems.
Current and planned projects in the Autoimmune Disease Treatment Device industry include expansion of blood purification device manufacturing facilities in North America and Europe, development of AI-enabled wearable immune monitoring platforms, establishment of advanced cleanroom assembly plants for biologic-compatible therapeutic devices, investment in smart neurostimulation technology production lines, construction of filtration membrane fabrication centers in Asia-Pacific, strategic partnerships between biotechnology companies and medical device manufacturers, localization of autoimmune treatment equipment manufacturing in emerging healthcare markets, modernization of robotic sterile assembly systems, development of remote patient management platforms, and large-scale R&D projects focused on personalized immune modulation technologies, minimally invasive treatment systems, digital therapeutics integration, and next-generation homecare autoimmune disease management solutions worldwide.
2025 Global Market Average Gross Profit Margin: 47%.
This report is a detailed and comprehensive analysis for global Autoimmune Disease Treatment Device market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Autoimmune Disease Treatment Device market size and forecasts, in consumption value ($ Million), 2021-2032
Global Autoimmune Disease Treatment Device market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Autoimmune Disease Treatment Device market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Autoimmune Disease Treatment Device market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Autoimmune Disease Treatment Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Autoimmune Disease Treatment Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Autoimmune Disease Treatment Device, with revenue, gross margin, and global market share of Autoimmune Disease Treatment Device from 2021 to 2026.
Chapter 3, the Autoimmune Disease Treatment Device competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Autoimmune Disease Treatment Device market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Autoimmune Disease Treatment Device.
Chapter 13, to describe Autoimmune Disease Treatment Device research findings and conclusion.
Autoimmune Disease Treatment Device refers to a category of medical devices designed to diagnose, manage, modulate, or therapeutically treat autoimmune disorders by regulating immune system activity, removing pathogenic substances from blood, delivering targeted stimulation, supporting biologic administration, or monitoring disease progression. These devices are used in the treatment of autoimmune conditions such as rheumatoid arthritis, lupus, multiple sclerosis, inflammatory bowel disease, psoriasis, myasthenia gravis, and type 1 diabetes. Autoimmune Disease Treatment Devices include plasmapheresis systems, immunoadsorption equipment, infusion pumps, neurostimulation devices, wearable monitoring systems, photopheresis systems, and targeted therapeutic delivery technologies that help improve disease management, reduce inflammatory activity, and enhance patient quality of life.
The Autoimmune Disease Treatment Device industry chain starts upstream with suppliers of medical-grade polymers, semiconductors, biosensors, filtration membranes, catheters, electronic components, biologic-compatible materials, and precision software systems, continues midstream through medical device manufacturers conducting product design, clinical testing, regulatory approval, intelligent system integration, assembly, sterilization, and distribution, and extends downstream to hospitals, specialty clinics, dialysis centers, research institutes, ambulatory care facilities, and homecare providers where devices are used for immune modulation, blood purification, biologic administration, disease monitoring, and long-term autoimmune disorder management, while service providers support maintenance, software upgrades, physician training, and post-treatment patient monitoring across global healthcare systems.
Current and planned projects in the Autoimmune Disease Treatment Device industry include expansion of blood purification device manufacturing facilities in North America and Europe, development of AI-enabled wearable immune monitoring platforms, establishment of advanced cleanroom assembly plants for biologic-compatible therapeutic devices, investment in smart neurostimulation technology production lines, construction of filtration membrane fabrication centers in Asia-Pacific, strategic partnerships between biotechnology companies and medical device manufacturers, localization of autoimmune treatment equipment manufacturing in emerging healthcare markets, modernization of robotic sterile assembly systems, development of remote patient management platforms, and large-scale R&D projects focused on personalized immune modulation technologies, minimally invasive treatment systems, digital therapeutics integration, and next-generation homecare autoimmune disease management solutions worldwide.
2025 Global Market Average Gross Profit Margin: 47%.
This report is a detailed and comprehensive analysis for global Autoimmune Disease Treatment Device market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Autoimmune Disease Treatment Device market size and forecasts, in consumption value ($ Million), 2021-2032
Global Autoimmune Disease Treatment Device market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Autoimmune Disease Treatment Device market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Autoimmune Disease Treatment Device market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Autoimmune Disease Treatment Device
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Autoimmune Disease Treatment Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Therapeutic Apheresis Devices
- Immunoadsorption Devices
- Extracorporeal Photopheresis (ECP) Systems
- Blood Purification Devices
- Cell Therapy / Immune Modulation Devices
- Neuromodulation Devices
- Others
- Stationary Device
- Portable Device
- Wearable Device
- Blood Purification
- Immune Modulation
- Inflammation Suppression
- Neuromodulation
- Biologic Drug Administration
- Others
- Systemic Autoimmune Diseases
- Gastrointestinal Autoimmune Disease
- Neurological Autoimmune Disorders
- Autoimmune Kidney Disease
- Dermatological Autoimmune Conditions
- Terumo Corporation
- Fresenius Medical Care
- Asahi Kasei Medical
- Baxter
- Therakos
- PhotoMedex
- Nikkiso Co., Ltd
- SWS Hemodialysis Care Co., Ltd
- WEGOBP
- Haemonetics
- Miltenyi Biotec
- B. Braun
- Kaneka
- Medica S.r.l / Aferetica
- Cala Health
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Autoimmune Disease Treatment Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Autoimmune Disease Treatment Device, with revenue, gross margin, and global market share of Autoimmune Disease Treatment Device from 2021 to 2026.
Chapter 3, the Autoimmune Disease Treatment Device competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Autoimmune Disease Treatment Device market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Autoimmune Disease Treatment Device.
Chapter 13, to describe Autoimmune Disease Treatment Device research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Autoimmune Disease Treatment Device by Type
1.3.1 Overview: Global Autoimmune Disease Treatment Device Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Autoimmune Disease Treatment Device Consumption Value Market Share by Type in 2025
1.3.3 Therapeutic Apheresis Devices
1.3.4 Immunoadsorption Devices
1.3.5 Extracorporeal Photopheresis (ECP) Systems
1.3.6 Blood Purification Devices
1.3.7 Cell Therapy / Immune Modulation Devices
1.3.8 Neuromodulation Devices
1.3.9 Others
1.4 Classification of Autoimmune Disease Treatment Device by Device Mobility
1.4.1 Overview: Global Autoimmune Disease Treatment Device Market Size by Device Mobility: 2021 Versus 2025 Versus 2032
1.4.2 Global Autoimmune Disease Treatment Device Consumption Value Market Share by Device Mobility in 2025
1.4.3 Stationary Device
1.4.4 Portable Device
1.4.5 Wearable Device
1.5 Classification of Autoimmune Disease Treatment Device by Therapeutic Mechanism
1.5.1 Overview: Global Autoimmune Disease Treatment Device Market Size by Therapeutic Mechanism: 2021 Versus 2025 Versus 2032
1.5.2 Global Autoimmune Disease Treatment Device Consumption Value Market Share by Therapeutic Mechanism in 2025
1.5.3 Blood Purification
1.5.4 Immune Modulation
1.5.5 Inflammation Suppression
1.5.6 Neuromodulation
1.5.7 Biologic Drug Administration
1.5.8 Others
1.6 Global Autoimmune Disease Treatment Device Market by Application
1.6.1 Overview: Global Autoimmune Disease Treatment Device Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Systemic Autoimmune Diseases
1.6.3 Gastrointestinal Autoimmune Disease
1.6.4 Neurological Autoimmune Disorders
1.6.5 Autoimmune Kidney Disease
1.6.6 Dermatological Autoimmune Conditions
1.7 Global Autoimmune Disease Treatment Device Market Size & Forecast
1.8 Global Autoimmune Disease Treatment Device Market Size and Forecast by Region
1.8.1 Global Autoimmune Disease Treatment Device Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Autoimmune Disease Treatment Device Market Size by Region, (2021-2032)
1.8.3 North America Autoimmune Disease Treatment Device Market Size and Prospect (2021-2032)
1.8.4 Europe Autoimmune Disease Treatment Device Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Autoimmune Disease Treatment Device Market Size and Prospect (2021-2032)
1.8.6 South America Autoimmune Disease Treatment Device Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Autoimmune Disease Treatment Device Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Terumo Corporation
2.1.1 Terumo Corporation Details
2.1.2 Terumo Corporation Major Business
2.1.3 Terumo Corporation Autoimmune Disease Treatment Device Product and Solutions
2.1.4 Terumo Corporation Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Terumo Corporation Recent Developments and Future Plans
2.2 Fresenius Medical Care
2.2.1 Fresenius Medical Care Details
2.2.2 Fresenius Medical Care Major Business
2.2.3 Fresenius Medical Care Autoimmune Disease Treatment Device Product and Solutions
2.2.4 Fresenius Medical Care Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Fresenius Medical Care Recent Developments and Future Plans
2.3 Asahi Kasei Medical
2.3.1 Asahi Kasei Medical Details
2.3.2 Asahi Kasei Medical Major Business
2.3.3 Asahi Kasei Medical Autoimmune Disease Treatment Device Product and Solutions
2.3.4 Asahi Kasei Medical Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Asahi Kasei Medical Recent Developments and Future Plans
2.4 Baxter
2.4.1 Baxter Details
2.4.2 Baxter Major Business
2.4.3 Baxter Autoimmune Disease Treatment Device Product and Solutions
2.4.4 Baxter Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Baxter Recent Developments and Future Plans
2.5 Therakos
2.5.1 Therakos Details
2.5.2 Therakos Major Business
2.5.3 Therakos Autoimmune Disease Treatment Device Product and Solutions
2.5.4 Therakos Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Therakos Recent Developments and Future Plans
2.6 PhotoMedex
2.6.1 PhotoMedex Details
2.6.2 PhotoMedex Major Business
2.6.3 PhotoMedex Autoimmune Disease Treatment Device Product and Solutions
2.6.4 PhotoMedex Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 PhotoMedex Recent Developments and Future Plans
2.7 Nikkiso Co., Ltd
2.7.1 Nikkiso Co., Ltd Details
2.7.2 Nikkiso Co., Ltd Major Business
2.7.3 Nikkiso Co., Ltd Autoimmune Disease Treatment Device Product and Solutions
2.7.4 Nikkiso Co., Ltd Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Nikkiso Co., Ltd Recent Developments and Future Plans
2.8 SWS Hemodialysis Care Co., Ltd
2.8.1 SWS Hemodialysis Care Co., Ltd Details
2.8.2 SWS Hemodialysis Care Co., Ltd Major Business
2.8.3 SWS Hemodialysis Care Co., Ltd Autoimmune Disease Treatment Device Product and Solutions
2.8.4 SWS Hemodialysis Care Co., Ltd Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 SWS Hemodialysis Care Co., Ltd Recent Developments and Future Plans
2.9 WEGOBP
2.9.1 WEGOBP Details
2.9.2 WEGOBP Major Business
2.9.3 WEGOBP Autoimmune Disease Treatment Device Product and Solutions
2.9.4 WEGOBP Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 WEGOBP Recent Developments and Future Plans
2.10 Haemonetics
2.10.1 Haemonetics Details
2.10.2 Haemonetics Major Business
2.10.3 Haemonetics Autoimmune Disease Treatment Device Product and Solutions
2.10.4 Haemonetics Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Haemonetics Recent Developments and Future Plans
2.11 Miltenyi Biotec
2.11.1 Miltenyi Biotec Details
2.11.2 Miltenyi Biotec Major Business
2.11.3 Miltenyi Biotec Autoimmune Disease Treatment Device Product and Solutions
2.11.4 Miltenyi Biotec Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Miltenyi Biotec Recent Developments and Future Plans
2.12 B. Braun
2.12.1 B. Braun Details
2.12.2 B. Braun Major Business
2.12.3 B. Braun Autoimmune Disease Treatment Device Product and Solutions
2.12.4 B. Braun Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 B. Braun Recent Developments and Future Plans
2.13 Kaneka
2.13.1 Kaneka Details
2.13.2 Kaneka Major Business
2.13.3 Kaneka Autoimmune Disease Treatment Device Product and Solutions
2.13.4 Kaneka Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Kaneka Recent Developments and Future Plans
2.14 Medica S.r.l / Aferetica
2.14.1 Medica S.r.l / Aferetica Details
2.14.2 Medica S.r.l / Aferetica Major Business
2.14.3 Medica S.r.l / Aferetica Autoimmune Disease Treatment Device Product and Solutions
2.14.4 Medica S.r.l / Aferetica Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Medica S.r.l / Aferetica Recent Developments and Future Plans
2.15 Cala Health
2.15.1 Cala Health Details
2.15.2 Cala Health Major Business
2.15.3 Cala Health Autoimmune Disease Treatment Device Product and Solutions
2.15.4 Cala Health Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Cala Health Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Autoimmune Disease Treatment Device Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Autoimmune Disease Treatment Device by Company Revenue
3.2.2 Top 3 Autoimmune Disease Treatment Device Players Market Share in 2025
3.2.3 Top 6 Autoimmune Disease Treatment Device Players Market Share in 2025
3.3 Autoimmune Disease Treatment Device Market: Overall Company Footprint Analysis
3.3.1 Autoimmune Disease Treatment Device Market: Region Footprint
3.3.2 Autoimmune Disease Treatment Device Market: Company Product Type Footprint
3.3.3 Autoimmune Disease Treatment Device Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Autoimmune Disease Treatment Device Consumption Value and Market Share by Type (2021-2026)
4.2 Global Autoimmune Disease Treatment Device Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Autoimmune Disease Treatment Device Consumption Value Market Share by Application (2021-2026)
5.2 Global Autoimmune Disease Treatment Device Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Autoimmune Disease Treatment Device Consumption Value by Type (2021-2032)
6.2 North America Autoimmune Disease Treatment Device Market Size by Application (2021-2032)
6.3 North America Autoimmune Disease Treatment Device Market Size by Country
6.3.1 North America Autoimmune Disease Treatment Device Consumption Value by Country (2021-2032)
6.3.2 United States Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
6.3.3 Canada Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
6.3.4 Mexico Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Autoimmune Disease Treatment Device Consumption Value by Type (2021-2032)
7.2 Europe Autoimmune Disease Treatment Device Consumption Value by Application (2021-2032)
7.3 Europe Autoimmune Disease Treatment Device Market Size by Country
7.3.1 Europe Autoimmune Disease Treatment Device Consumption Value by Country (2021-2032)
7.3.2 Germany Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
7.3.3 France Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
7.3.5 Russia Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
7.3.6 Italy Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Autoimmune Disease Treatment Device Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Autoimmune Disease Treatment Device Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Autoimmune Disease Treatment Device Market Size by Region
8.3.1 Asia-Pacific Autoimmune Disease Treatment Device Consumption Value by Region (2021-2032)
8.3.2 China Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
8.3.3 Japan Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
8.3.4 South Korea Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
8.3.5 India Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
8.3.7 Australia Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Autoimmune Disease Treatment Device Consumption Value by Type (2021-2032)
9.2 South America Autoimmune Disease Treatment Device Consumption Value by Application (2021-2032)
9.3 South America Autoimmune Disease Treatment Device Market Size by Country
9.3.1 South America Autoimmune Disease Treatment Device Consumption Value by Country (2021-2032)
9.3.2 Brazil Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
9.3.3 Argentina Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Autoimmune Disease Treatment Device Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Autoimmune Disease Treatment Device Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Autoimmune Disease Treatment Device Market Size by Country
10.3.1 Middle East & Africa Autoimmune Disease Treatment Device Consumption Value by Country (2021-2032)
10.3.2 Turkey Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
10.3.4 UAE Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Autoimmune Disease Treatment Device Market Drivers
11.2 Autoimmune Disease Treatment Device Market Restraints
11.3 Autoimmune Disease Treatment Device Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Autoimmune Disease Treatment Device Industry Chain
12.2 Autoimmune Disease Treatment Device Upstream Analysis
12.3 Autoimmune Disease Treatment Device Midstream Analysis
12.4 Autoimmune Disease Treatment Device Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Autoimmune Disease Treatment Device by Type
1.3.1 Overview: Global Autoimmune Disease Treatment Device Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Autoimmune Disease Treatment Device Consumption Value Market Share by Type in 2025
1.3.3 Therapeutic Apheresis Devices
1.3.4 Immunoadsorption Devices
1.3.5 Extracorporeal Photopheresis (ECP) Systems
1.3.6 Blood Purification Devices
1.3.7 Cell Therapy / Immune Modulation Devices
1.3.8 Neuromodulation Devices
1.3.9 Others
1.4 Classification of Autoimmune Disease Treatment Device by Device Mobility
1.4.1 Overview: Global Autoimmune Disease Treatment Device Market Size by Device Mobility: 2021 Versus 2025 Versus 2032
1.4.2 Global Autoimmune Disease Treatment Device Consumption Value Market Share by Device Mobility in 2025
1.4.3 Stationary Device
1.4.4 Portable Device
1.4.5 Wearable Device
1.5 Classification of Autoimmune Disease Treatment Device by Therapeutic Mechanism
1.5.1 Overview: Global Autoimmune Disease Treatment Device Market Size by Therapeutic Mechanism: 2021 Versus 2025 Versus 2032
1.5.2 Global Autoimmune Disease Treatment Device Consumption Value Market Share by Therapeutic Mechanism in 2025
1.5.3 Blood Purification
1.5.4 Immune Modulation
1.5.5 Inflammation Suppression
1.5.6 Neuromodulation
1.5.7 Biologic Drug Administration
1.5.8 Others
1.6 Global Autoimmune Disease Treatment Device Market by Application
1.6.1 Overview: Global Autoimmune Disease Treatment Device Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Systemic Autoimmune Diseases
1.6.3 Gastrointestinal Autoimmune Disease
1.6.4 Neurological Autoimmune Disorders
1.6.5 Autoimmune Kidney Disease
1.6.6 Dermatological Autoimmune Conditions
1.7 Global Autoimmune Disease Treatment Device Market Size & Forecast
1.8 Global Autoimmune Disease Treatment Device Market Size and Forecast by Region
1.8.1 Global Autoimmune Disease Treatment Device Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Autoimmune Disease Treatment Device Market Size by Region, (2021-2032)
1.8.3 North America Autoimmune Disease Treatment Device Market Size and Prospect (2021-2032)
1.8.4 Europe Autoimmune Disease Treatment Device Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Autoimmune Disease Treatment Device Market Size and Prospect (2021-2032)
1.8.6 South America Autoimmune Disease Treatment Device Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Autoimmune Disease Treatment Device Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Terumo Corporation
2.1.1 Terumo Corporation Details
2.1.2 Terumo Corporation Major Business
2.1.3 Terumo Corporation Autoimmune Disease Treatment Device Product and Solutions
2.1.4 Terumo Corporation Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Terumo Corporation Recent Developments and Future Plans
2.2 Fresenius Medical Care
2.2.1 Fresenius Medical Care Details
2.2.2 Fresenius Medical Care Major Business
2.2.3 Fresenius Medical Care Autoimmune Disease Treatment Device Product and Solutions
2.2.4 Fresenius Medical Care Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Fresenius Medical Care Recent Developments and Future Plans
2.3 Asahi Kasei Medical
2.3.1 Asahi Kasei Medical Details
2.3.2 Asahi Kasei Medical Major Business
2.3.3 Asahi Kasei Medical Autoimmune Disease Treatment Device Product and Solutions
2.3.4 Asahi Kasei Medical Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Asahi Kasei Medical Recent Developments and Future Plans
2.4 Baxter
2.4.1 Baxter Details
2.4.2 Baxter Major Business
2.4.3 Baxter Autoimmune Disease Treatment Device Product and Solutions
2.4.4 Baxter Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Baxter Recent Developments and Future Plans
2.5 Therakos
2.5.1 Therakos Details
2.5.2 Therakos Major Business
2.5.3 Therakos Autoimmune Disease Treatment Device Product and Solutions
2.5.4 Therakos Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Therakos Recent Developments and Future Plans
2.6 PhotoMedex
2.6.1 PhotoMedex Details
2.6.2 PhotoMedex Major Business
2.6.3 PhotoMedex Autoimmune Disease Treatment Device Product and Solutions
2.6.4 PhotoMedex Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 PhotoMedex Recent Developments and Future Plans
2.7 Nikkiso Co., Ltd
2.7.1 Nikkiso Co., Ltd Details
2.7.2 Nikkiso Co., Ltd Major Business
2.7.3 Nikkiso Co., Ltd Autoimmune Disease Treatment Device Product and Solutions
2.7.4 Nikkiso Co., Ltd Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Nikkiso Co., Ltd Recent Developments and Future Plans
2.8 SWS Hemodialysis Care Co., Ltd
2.8.1 SWS Hemodialysis Care Co., Ltd Details
2.8.2 SWS Hemodialysis Care Co., Ltd Major Business
2.8.3 SWS Hemodialysis Care Co., Ltd Autoimmune Disease Treatment Device Product and Solutions
2.8.4 SWS Hemodialysis Care Co., Ltd Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 SWS Hemodialysis Care Co., Ltd Recent Developments and Future Plans
2.9 WEGOBP
2.9.1 WEGOBP Details
2.9.2 WEGOBP Major Business
2.9.3 WEGOBP Autoimmune Disease Treatment Device Product and Solutions
2.9.4 WEGOBP Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 WEGOBP Recent Developments and Future Plans
2.10 Haemonetics
2.10.1 Haemonetics Details
2.10.2 Haemonetics Major Business
2.10.3 Haemonetics Autoimmune Disease Treatment Device Product and Solutions
2.10.4 Haemonetics Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Haemonetics Recent Developments and Future Plans
2.11 Miltenyi Biotec
2.11.1 Miltenyi Biotec Details
2.11.2 Miltenyi Biotec Major Business
2.11.3 Miltenyi Biotec Autoimmune Disease Treatment Device Product and Solutions
2.11.4 Miltenyi Biotec Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Miltenyi Biotec Recent Developments and Future Plans
2.12 B. Braun
2.12.1 B. Braun Details
2.12.2 B. Braun Major Business
2.12.3 B. Braun Autoimmune Disease Treatment Device Product and Solutions
2.12.4 B. Braun Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 B. Braun Recent Developments and Future Plans
2.13 Kaneka
2.13.1 Kaneka Details
2.13.2 Kaneka Major Business
2.13.3 Kaneka Autoimmune Disease Treatment Device Product and Solutions
2.13.4 Kaneka Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Kaneka Recent Developments and Future Plans
2.14 Medica S.r.l / Aferetica
2.14.1 Medica S.r.l / Aferetica Details
2.14.2 Medica S.r.l / Aferetica Major Business
2.14.3 Medica S.r.l / Aferetica Autoimmune Disease Treatment Device Product and Solutions
2.14.4 Medica S.r.l / Aferetica Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Medica S.r.l / Aferetica Recent Developments and Future Plans
2.15 Cala Health
2.15.1 Cala Health Details
2.15.2 Cala Health Major Business
2.15.3 Cala Health Autoimmune Disease Treatment Device Product and Solutions
2.15.4 Cala Health Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Cala Health Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Autoimmune Disease Treatment Device Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Autoimmune Disease Treatment Device by Company Revenue
3.2.2 Top 3 Autoimmune Disease Treatment Device Players Market Share in 2025
3.2.3 Top 6 Autoimmune Disease Treatment Device Players Market Share in 2025
3.3 Autoimmune Disease Treatment Device Market: Overall Company Footprint Analysis
3.3.1 Autoimmune Disease Treatment Device Market: Region Footprint
3.3.2 Autoimmune Disease Treatment Device Market: Company Product Type Footprint
3.3.3 Autoimmune Disease Treatment Device Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Autoimmune Disease Treatment Device Consumption Value and Market Share by Type (2021-2026)
4.2 Global Autoimmune Disease Treatment Device Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Autoimmune Disease Treatment Device Consumption Value Market Share by Application (2021-2026)
5.2 Global Autoimmune Disease Treatment Device Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Autoimmune Disease Treatment Device Consumption Value by Type (2021-2032)
6.2 North America Autoimmune Disease Treatment Device Market Size by Application (2021-2032)
6.3 North America Autoimmune Disease Treatment Device Market Size by Country
6.3.1 North America Autoimmune Disease Treatment Device Consumption Value by Country (2021-2032)
6.3.2 United States Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
6.3.3 Canada Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
6.3.4 Mexico Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Autoimmune Disease Treatment Device Consumption Value by Type (2021-2032)
7.2 Europe Autoimmune Disease Treatment Device Consumption Value by Application (2021-2032)
7.3 Europe Autoimmune Disease Treatment Device Market Size by Country
7.3.1 Europe Autoimmune Disease Treatment Device Consumption Value by Country (2021-2032)
7.3.2 Germany Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
7.3.3 France Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
7.3.5 Russia Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
7.3.6 Italy Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Autoimmune Disease Treatment Device Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Autoimmune Disease Treatment Device Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Autoimmune Disease Treatment Device Market Size by Region
8.3.1 Asia-Pacific Autoimmune Disease Treatment Device Consumption Value by Region (2021-2032)
8.3.2 China Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
8.3.3 Japan Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
8.3.4 South Korea Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
8.3.5 India Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
8.3.7 Australia Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Autoimmune Disease Treatment Device Consumption Value by Type (2021-2032)
9.2 South America Autoimmune Disease Treatment Device Consumption Value by Application (2021-2032)
9.3 South America Autoimmune Disease Treatment Device Market Size by Country
9.3.1 South America Autoimmune Disease Treatment Device Consumption Value by Country (2021-2032)
9.3.2 Brazil Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
9.3.3 Argentina Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Autoimmune Disease Treatment Device Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Autoimmune Disease Treatment Device Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Autoimmune Disease Treatment Device Market Size by Country
10.3.1 Middle East & Africa Autoimmune Disease Treatment Device Consumption Value by Country (2021-2032)
10.3.2 Turkey Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
10.3.4 UAE Autoimmune Disease Treatment Device Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Autoimmune Disease Treatment Device Market Drivers
11.2 Autoimmune Disease Treatment Device Market Restraints
11.3 Autoimmune Disease Treatment Device Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Autoimmune Disease Treatment Device Industry Chain
12.2 Autoimmune Disease Treatment Device Upstream Analysis
12.3 Autoimmune Disease Treatment Device Midstream Analysis
12.4 Autoimmune Disease Treatment Device Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Medical-grade Cobalt-60 Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Medical-grade Cobalt-60 Consumption Value by Source Form, (USD Million), 2021 & 2025 & 2032
Table 3. Global Medical-grade Cobalt-60 Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Table 4. Global Medical-grade Cobalt-60 Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Nordion Basic Information, Manufacturing Base and Competitors
Table 6. Nordion Major Business
Table 7. Nordion Medical-grade Cobalt-60 Product and Services
Table 8. Nordion Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Nordion Recent Developments/Updates
Table 10. China National Nuclear Corporation Basic Information, Manufacturing Base and Competitors
Table 11. China National Nuclear Corporation Major Business
Table 12. China National Nuclear Corporation Medical-grade Cobalt-60 Product and Services
Table 13. China National Nuclear Corporation Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. China National Nuclear Corporation Recent Developments/Updates
Table 15. Rosatom Basic Information, Manufacturing Base and Competitors
Table 16. Rosatom Major Business
Table 17. Rosatom Medical-grade Cobalt-60 Product and Services
Table 18. Rosatom Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Rosatom Recent Developments/Updates
Table 20. Eckert & Ziegler Strahlen Basic Information, Manufacturing Base and Competitors
Table 21. Eckert & Ziegler Strahlen Major Business
Table 22. Eckert & Ziegler Strahlen Medical-grade Cobalt-60 Product and Services
Table 23. Eckert & Ziegler Strahlen Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Eckert & Ziegler Strahlen Recent Developments/Updates
Table 25. Polatom Basic Information, Manufacturing Base and Competitors
Table 26. Polatom Major Business
Table 27. Polatom Medical-grade Cobalt-60 Product and Services
Table 28. Polatom Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Polatom Recent Developments/Updates
Table 30. NTP Basic Information, Manufacturing Base and Competitors
Table 31. NTP Major Business
Table 32. NTP Medical-grade Cobalt-60 Product and Services
Table 33. NTP Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. NTP Recent Developments/Updates
Table 35. DIOXITEK Basic Information, Manufacturing Base and Competitors
Table 36. DIOXITEK Major Business
Table 37. DIOXITEK Medical-grade Cobalt-60 Product and Services
Table 38. DIOXITEK Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. DIOXITEK Recent Developments/Updates
Table 40. Global Medical-grade Cobalt-60 Sales Quantity by Manufacturer (2021-2026) & (Curie)
Table 41. Global Medical-grade Cobalt-60 Revenue by Manufacturer (2021-2026) & (USD Million)
Table 42. Global Medical-grade Cobalt-60 Average Price by Manufacturer (2021-2026) & (US$/Curie)
Table 43. Market Position of Manufacturers in Medical-grade Cobalt-60, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 44. Head Office and Medical-grade Cobalt-60 Production Site of Key Manufacturer
Table 45. Medical-grade Cobalt-60 Market: Company Product Type Footprint
Table 46. Medical-grade Cobalt-60 Market: Company Product Application Footprint
Table 47. Medical-grade Cobalt-60 New Market Entrants and Barriers to Market Entry
Table 48. Medical-grade Cobalt-60 Mergers, Acquisition, Agreements, and Collaborations
Table 49. Global Medical-grade Cobalt-60 Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 50. Global Medical-grade Cobalt-60 Sales Quantity by Region (2021-2026) & (Curie)
Table 51. Global Medical-grade Cobalt-60 Sales Quantity by Region (2027-2032) & (Curie)
Table 52. Global Medical-grade Cobalt-60 Consumption Value by Region (2021-2026) & (USD Million)
Table 53. Global Medical-grade Cobalt-60 Consumption Value by Region (2027-2032) & (USD Million)
Table 54. Global Medical-grade Cobalt-60 Average Price by Region (2021-2026) & (US$/Curie)
Table 55. Global Medical-grade Cobalt-60 Average Price by Region (2027-2032) & (US$/Curie)
Table 56. Global Medical-grade Cobalt-60 Sales Quantity by Type (2021-2026) & (Curie)
Table 57. Global Medical-grade Cobalt-60 Sales Quantity by Type (2027-2032) & (Curie)
Table 58. Global Medical-grade Cobalt-60 Consumption Value by Type (2021-2026) & (USD Million)
Table 59. Global Medical-grade Cobalt-60 Consumption Value by Type (2027-2032) & (USD Million)
Table 60. Global Medical-grade Cobalt-60 Average Price by Type (2021-2026) & (US$/Curie)
Table 61. Global Medical-grade Cobalt-60 Average Price by Type (2027-2032) & (US$/Curie)
Table 62. Global Medical-grade Cobalt-60 Sales Quantity by Application (2021-2026) & (Curie)
Table 63. Global Medical-grade Cobalt-60 Sales Quantity by Application (2027-2032) & (Curie)
Table 64. Global Medical-grade Cobalt-60 Consumption Value by Application (2021-2026) & (USD Million)
Table 65. Global Medical-grade Cobalt-60 Consumption Value by Application (2027-2032) & (USD Million)
Table 66. Global Medical-grade Cobalt-60 Average Price by Application (2021-2026) & (US$/Curie)
Table 67. Global Medical-grade Cobalt-60 Average Price by Application (2027-2032) & (US$/Curie)
Table 68. North America Medical-grade Cobalt-60 Sales Quantity by Type (2021-2026) & (Curie)
Table 69. North America Medical-grade Cobalt-60 Sales Quantity by Type (2027-2032) & (Curie)
Table 70. North America Medical-grade Cobalt-60 Sales Quantity by Application (2021-2026) & (Curie)
Table 71. North America Medical-grade Cobalt-60 Sales Quantity by Application (2027-2032) & (Curie)
Table 72. North America Medical-grade Cobalt-60 Sales Quantity by Country (2021-2026) & (Curie)
Table 73. North America Medical-grade Cobalt-60 Sales Quantity by Country (2027-2032) & (Curie)
Table 74. North America Medical-grade Cobalt-60 Consumption Value by Country (2021-2026) & (USD Million)
Table 75. North America Medical-grade Cobalt-60 Consumption Value by Country (2027-2032) & (USD Million)
Table 76. Europe Medical-grade Cobalt-60 Sales Quantity by Type (2021-2026) & (Curie)
Table 77. Europe Medical-grade Cobalt-60 Sales Quantity by Type (2027-2032) & (Curie)
Table 78. Europe Medical-grade Cobalt-60 Sales Quantity by Application (2021-2026) & (Curie)
Table 79. Europe Medical-grade Cobalt-60 Sales Quantity by Application (2027-2032) & (Curie)
Table 80. Europe Medical-grade Cobalt-60 Sales Quantity by Country (2021-2026) & (Curie)
Table 81. Europe Medical-grade Cobalt-60 Sales Quantity by Country (2027-2032) & (Curie)
Table 82. Europe Medical-grade Cobalt-60 Consumption Value by Country (2021-2026) & (USD Million)
Table 83. Europe Medical-grade Cobalt-60 Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity by Type (2021-2026) & (Curie)
Table 85. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity by Type (2027-2032) & (Curie)
Table 86. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity by Application (2021-2026) & (Curie)
Table 87. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity by Application (2027-2032) & (Curie)
Table 88. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity by Region (2021-2026) & (Curie)
Table 89. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity by Region (2027-2032) & (Curie)
Table 90. Asia-Pacific Medical-grade Cobalt-60 Consumption Value by Region (2021-2026) & (USD Million)
Table 91. Asia-Pacific Medical-grade Cobalt-60 Consumption Value by Region (2027-2032) & (USD Million)
Table 92. South America Medical-grade Cobalt-60 Sales Quantity by Type (2021-2026) & (Curie)
Table 93. South America Medical-grade Cobalt-60 Sales Quantity by Type (2027-2032) & (Curie)
Table 94. South America Medical-grade Cobalt-60 Sales Quantity by Application (2021-2026) & (Curie)
Table 95. South America Medical-grade Cobalt-60 Sales Quantity by Application (2027-2032) & (Curie)
Table 96. South America Medical-grade Cobalt-60 Sales Quantity by Country (2021-2026) & (Curie)
Table 97. South America Medical-grade Cobalt-60 Sales Quantity by Country (2027-2032) & (Curie)
Table 98. South America Medical-grade Cobalt-60 Consumption Value by Country (2021-2026) & (USD Million)
Table 99. South America Medical-grade Cobalt-60 Consumption Value by Country (2027-2032) & (USD Million)
Table 100. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity by Type (2021-2026) & (Curie)
Table 101. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity by Type (2027-2032) & (Curie)
Table 102. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity by Application (2021-2026) & (Curie)
Table 103. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity by Application (2027-2032) & (Curie)
Table 104. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity by Country (2021-2026) & (Curie)
Table 105. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity by Country (2027-2032) & (Curie)
Table 106. Middle East & Africa Medical-grade Cobalt-60 Consumption Value by Country (2021-2026) & (USD Million)
Table 107. Middle East & Africa Medical-grade Cobalt-60 Consumption Value by Country (2027-2032) & (USD Million)
Table 108. Medical-grade Cobalt-60 Raw Material
Table 109. Key Manufacturers of Medical-grade Cobalt-60 Raw Materials
Table 110. Medical-grade Cobalt-60 Typical Distributors
Table 111. Medical-grade Cobalt-60 Typical Customers
Table 1. Global Medical-grade Cobalt-60 Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Medical-grade Cobalt-60 Consumption Value by Source Form, (USD Million), 2021 & 2025 & 2032
Table 3. Global Medical-grade Cobalt-60 Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Table 4. Global Medical-grade Cobalt-60 Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Nordion Basic Information, Manufacturing Base and Competitors
Table 6. Nordion Major Business
Table 7. Nordion Medical-grade Cobalt-60 Product and Services
Table 8. Nordion Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Nordion Recent Developments/Updates
Table 10. China National Nuclear Corporation Basic Information, Manufacturing Base and Competitors
Table 11. China National Nuclear Corporation Major Business
Table 12. China National Nuclear Corporation Medical-grade Cobalt-60 Product and Services
Table 13. China National Nuclear Corporation Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. China National Nuclear Corporation Recent Developments/Updates
Table 15. Rosatom Basic Information, Manufacturing Base and Competitors
Table 16. Rosatom Major Business
Table 17. Rosatom Medical-grade Cobalt-60 Product and Services
Table 18. Rosatom Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Rosatom Recent Developments/Updates
Table 20. Eckert & Ziegler Strahlen Basic Information, Manufacturing Base and Competitors
Table 21. Eckert & Ziegler Strahlen Major Business
Table 22. Eckert & Ziegler Strahlen Medical-grade Cobalt-60 Product and Services
Table 23. Eckert & Ziegler Strahlen Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Eckert & Ziegler Strahlen Recent Developments/Updates
Table 25. Polatom Basic Information, Manufacturing Base and Competitors
Table 26. Polatom Major Business
Table 27. Polatom Medical-grade Cobalt-60 Product and Services
Table 28. Polatom Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Polatom Recent Developments/Updates
Table 30. NTP Basic Information, Manufacturing Base and Competitors
Table 31. NTP Major Business
Table 32. NTP Medical-grade Cobalt-60 Product and Services
Table 33. NTP Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. NTP Recent Developments/Updates
Table 35. DIOXITEK Basic Information, Manufacturing Base and Competitors
Table 36. DIOXITEK Major Business
Table 37. DIOXITEK Medical-grade Cobalt-60 Product and Services
Table 38. DIOXITEK Medical-grade Cobalt-60 Sales Quantity (Curie), Average Price (US$/Curie), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. DIOXITEK Recent Developments/Updates
Table 40. Global Medical-grade Cobalt-60 Sales Quantity by Manufacturer (2021-2026) & (Curie)
Table 41. Global Medical-grade Cobalt-60 Revenue by Manufacturer (2021-2026) & (USD Million)
Table 42. Global Medical-grade Cobalt-60 Average Price by Manufacturer (2021-2026) & (US$/Curie)
Table 43. Market Position of Manufacturers in Medical-grade Cobalt-60, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 44. Head Office and Medical-grade Cobalt-60 Production Site of Key Manufacturer
Table 45. Medical-grade Cobalt-60 Market: Company Product Type Footprint
Table 46. Medical-grade Cobalt-60 Market: Company Product Application Footprint
Table 47. Medical-grade Cobalt-60 New Market Entrants and Barriers to Market Entry
Table 48. Medical-grade Cobalt-60 Mergers, Acquisition, Agreements, and Collaborations
Table 49. Global Medical-grade Cobalt-60 Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 50. Global Medical-grade Cobalt-60 Sales Quantity by Region (2021-2026) & (Curie)
Table 51. Global Medical-grade Cobalt-60 Sales Quantity by Region (2027-2032) & (Curie)
Table 52. Global Medical-grade Cobalt-60 Consumption Value by Region (2021-2026) & (USD Million)
Table 53. Global Medical-grade Cobalt-60 Consumption Value by Region (2027-2032) & (USD Million)
Table 54. Global Medical-grade Cobalt-60 Average Price by Region (2021-2026) & (US$/Curie)
Table 55. Global Medical-grade Cobalt-60 Average Price by Region (2027-2032) & (US$/Curie)
Table 56. Global Medical-grade Cobalt-60 Sales Quantity by Type (2021-2026) & (Curie)
Table 57. Global Medical-grade Cobalt-60 Sales Quantity by Type (2027-2032) & (Curie)
Table 58. Global Medical-grade Cobalt-60 Consumption Value by Type (2021-2026) & (USD Million)
Table 59. Global Medical-grade Cobalt-60 Consumption Value by Type (2027-2032) & (USD Million)
Table 60. Global Medical-grade Cobalt-60 Average Price by Type (2021-2026) & (US$/Curie)
Table 61. Global Medical-grade Cobalt-60 Average Price by Type (2027-2032) & (US$/Curie)
Table 62. Global Medical-grade Cobalt-60 Sales Quantity by Application (2021-2026) & (Curie)
Table 63. Global Medical-grade Cobalt-60 Sales Quantity by Application (2027-2032) & (Curie)
Table 64. Global Medical-grade Cobalt-60 Consumption Value by Application (2021-2026) & (USD Million)
Table 65. Global Medical-grade Cobalt-60 Consumption Value by Application (2027-2032) & (USD Million)
Table 66. Global Medical-grade Cobalt-60 Average Price by Application (2021-2026) & (US$/Curie)
Table 67. Global Medical-grade Cobalt-60 Average Price by Application (2027-2032) & (US$/Curie)
Table 68. North America Medical-grade Cobalt-60 Sales Quantity by Type (2021-2026) & (Curie)
Table 69. North America Medical-grade Cobalt-60 Sales Quantity by Type (2027-2032) & (Curie)
Table 70. North America Medical-grade Cobalt-60 Sales Quantity by Application (2021-2026) & (Curie)
Table 71. North America Medical-grade Cobalt-60 Sales Quantity by Application (2027-2032) & (Curie)
Table 72. North America Medical-grade Cobalt-60 Sales Quantity by Country (2021-2026) & (Curie)
Table 73. North America Medical-grade Cobalt-60 Sales Quantity by Country (2027-2032) & (Curie)
Table 74. North America Medical-grade Cobalt-60 Consumption Value by Country (2021-2026) & (USD Million)
Table 75. North America Medical-grade Cobalt-60 Consumption Value by Country (2027-2032) & (USD Million)
Table 76. Europe Medical-grade Cobalt-60 Sales Quantity by Type (2021-2026) & (Curie)
Table 77. Europe Medical-grade Cobalt-60 Sales Quantity by Type (2027-2032) & (Curie)
Table 78. Europe Medical-grade Cobalt-60 Sales Quantity by Application (2021-2026) & (Curie)
Table 79. Europe Medical-grade Cobalt-60 Sales Quantity by Application (2027-2032) & (Curie)
Table 80. Europe Medical-grade Cobalt-60 Sales Quantity by Country (2021-2026) & (Curie)
Table 81. Europe Medical-grade Cobalt-60 Sales Quantity by Country (2027-2032) & (Curie)
Table 82. Europe Medical-grade Cobalt-60 Consumption Value by Country (2021-2026) & (USD Million)
Table 83. Europe Medical-grade Cobalt-60 Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity by Type (2021-2026) & (Curie)
Table 85. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity by Type (2027-2032) & (Curie)
Table 86. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity by Application (2021-2026) & (Curie)
Table 87. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity by Application (2027-2032) & (Curie)
Table 88. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity by Region (2021-2026) & (Curie)
Table 89. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity by Region (2027-2032) & (Curie)
Table 90. Asia-Pacific Medical-grade Cobalt-60 Consumption Value by Region (2021-2026) & (USD Million)
Table 91. Asia-Pacific Medical-grade Cobalt-60 Consumption Value by Region (2027-2032) & (USD Million)
Table 92. South America Medical-grade Cobalt-60 Sales Quantity by Type (2021-2026) & (Curie)
Table 93. South America Medical-grade Cobalt-60 Sales Quantity by Type (2027-2032) & (Curie)
Table 94. South America Medical-grade Cobalt-60 Sales Quantity by Application (2021-2026) & (Curie)
Table 95. South America Medical-grade Cobalt-60 Sales Quantity by Application (2027-2032) & (Curie)
Table 96. South America Medical-grade Cobalt-60 Sales Quantity by Country (2021-2026) & (Curie)
Table 97. South America Medical-grade Cobalt-60 Sales Quantity by Country (2027-2032) & (Curie)
Table 98. South America Medical-grade Cobalt-60 Consumption Value by Country (2021-2026) & (USD Million)
Table 99. South America Medical-grade Cobalt-60 Consumption Value by Country (2027-2032) & (USD Million)
Table 100. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity by Type (2021-2026) & (Curie)
Table 101. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity by Type (2027-2032) & (Curie)
Table 102. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity by Application (2021-2026) & (Curie)
Table 103. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity by Application (2027-2032) & (Curie)
Table 104. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity by Country (2021-2026) & (Curie)
Table 105. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity by Country (2027-2032) & (Curie)
Table 106. Middle East & Africa Medical-grade Cobalt-60 Consumption Value by Country (2021-2026) & (USD Million)
Table 107. Middle East & Africa Medical-grade Cobalt-60 Consumption Value by Country (2027-2032) & (USD Million)
Table 108. Medical-grade Cobalt-60 Raw Material
Table 109. Key Manufacturers of Medical-grade Cobalt-60 Raw Materials
Table 110. Medical-grade Cobalt-60 Typical Distributors
Table 111. Medical-grade Cobalt-60 Typical Customers
LIST OF FIGURES
Figure 1. Medical-grade Cobalt-60 Picture
Figure 2. Global Medical-grade Cobalt-60 Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Medical-grade Cobalt-60 Revenue Market Share by Type in 2025
Figure 4. High Specific Activity Cobalt-60 Examples
Figure 5. Low Specific Activity Cobalt-60 Examples
Figure 6. Global Medical-grade Cobalt-60 Revenue by Source Form, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Medical-grade Cobalt-60 Revenue Market Share by Source Form in 2025
Figure 8. Sealed Source Examples
Figure 9. Source Module Examples
Figure 10. Global Medical-grade Cobalt-60 Revenue by End User, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Medical-grade Cobalt-60 Revenue Market Share by End User in 2025
Figure 12. Source for Gamma Knife Examples
Figure 13. Source for Cobalt Radiotherapy System Examples
Figure 14. Other Examples
Figure 15. Global Medical-grade Cobalt-60 Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Medical-grade Cobalt-60 Revenue Market Share by Application in 2025
Figure 17. Medical Devices Examples
Figure 18. Medical Radiotherapy Examples
Figure 19. Others Examples
Figure 20. Global Medical-grade Cobalt-60 Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 21. Global Medical-grade Cobalt-60 Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 22. Global Medical-grade Cobalt-60 Sales Quantity (2021-2032) & (Curie)
Figure 23. Global Medical-grade Cobalt-60 Price (2021-2032) & (US$/Curie)
Figure 24. Global Medical-grade Cobalt-60 Sales Quantity Market Share by Manufacturer in 2025
Figure 25. Global Medical-grade Cobalt-60 Revenue Market Share by Manufacturer in 2025
Figure 26. Producer Shipments of Medical-grade Cobalt-60 by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 27. Top 3 Medical-grade Cobalt-60 Manufacturer (Revenue) Market Share in 2025
Figure 28. Top 6 Medical-grade Cobalt-60 Manufacturer (Revenue) Market Share in 2025
Figure 29. Global Medical-grade Cobalt-60 Sales Quantity Market Share by Region (2021-2032)
Figure 30. Global Medical-grade Cobalt-60 Consumption Value Market Share by Region (2021-2032)
Figure 31. North America Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 32. Europe Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 33. Asia-Pacific Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 34. South America Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 35. Middle East & Africa Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 36. Global Medical-grade Cobalt-60 Sales Quantity Market Share by Type (2021-2032)
Figure 37. Global Medical-grade Cobalt-60 Consumption Value Market Share by Type (2021-2032)
Figure 38. Global Medical-grade Cobalt-60 Average Price by Type (2021-2032) & (US$/Curie)
Figure 39. Global Medical-grade Cobalt-60 Sales Quantity Market Share by Application (2021-2032)
Figure 40. Global Medical-grade Cobalt-60 Revenue Market Share by Application (2021-2032)
Figure 41. Global Medical-grade Cobalt-60 Average Price by Application (2021-2032) & (US$/Curie)
Figure 42. North America Medical-grade Cobalt-60 Sales Quantity Market Share by Type (2021-2032)
Figure 43. North America Medical-grade Cobalt-60 Sales Quantity Market Share by Application (2021-2032)
Figure 44. North America Medical-grade Cobalt-60 Sales Quantity Market Share by Country (2021-2032)
Figure 45. North America Medical-grade Cobalt-60 Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Medical-grade Cobalt-60 Sales Quantity Market Share by Type (2021-2032)
Figure 50. Europe Medical-grade Cobalt-60 Sales Quantity Market Share by Application (2021-2032)
Figure 51. Europe Medical-grade Cobalt-60 Sales Quantity Market Share by Country (2021-2032)
Figure 52. Europe Medical-grade Cobalt-60 Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 54. France Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity Market Share by Region (2021-2032)
Figure 61. Asia-Pacific Medical-grade Cobalt-60 Consumption Value Market Share by Region (2021-2032)
Figure 62. China Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 65. India Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Medical-grade Cobalt-60 Sales Quantity Market Share by Type (2021-2032)
Figure 69. South America Medical-grade Cobalt-60 Sales Quantity Market Share by Application (2021-2032)
Figure 70. South America Medical-grade Cobalt-60 Sales Quantity Market Share by Country (2021-2032)
Figure 71. South America Medical-grade Cobalt-60 Consumption Value Market Share by Country (2021-2032)
Figure 72. Brazil Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 73. Argentina Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 74. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity Market Share by Type (2021-2032)
Figure 75. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity Market Share by Application (2021-2032)
Figure 76. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity Market Share by Country (2021-2032)
Figure 77. Middle East & Africa Medical-grade Cobalt-60 Consumption Value Market Share by Country (2021-2032)
Figure 78. Turkey Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 79. Egypt Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 80. Saudi Arabia Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 81. South Africa Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 82. Medical-grade Cobalt-60 Market Drivers
Figure 83. Medical-grade Cobalt-60 Market Restraints
Figure 84. Medical-grade Cobalt-60 Market Trends
Figure 85. Porters Five Forces Analysis
Figure 86. Manufacturing Cost Structure Analysis of Medical-grade Cobalt-60 in 2025
Figure 87. Manufacturing Process Analysis of Medical-grade Cobalt-60
Figure 88. Medical-grade Cobalt-60 Industrial Chain
Figure 89. Sales Channel: Direct to End-User vs Distributors
Figure 90. Direct Channel Pros & Cons
Figure 91. Indirect Channel Pros & Cons
Figure 92. Methodology
Figure 93. Research Process and Data Source
Figure 1. Medical-grade Cobalt-60 Picture
Figure 2. Global Medical-grade Cobalt-60 Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Medical-grade Cobalt-60 Revenue Market Share by Type in 2025
Figure 4. High Specific Activity Cobalt-60 Examples
Figure 5. Low Specific Activity Cobalt-60 Examples
Figure 6. Global Medical-grade Cobalt-60 Revenue by Source Form, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Medical-grade Cobalt-60 Revenue Market Share by Source Form in 2025
Figure 8. Sealed Source Examples
Figure 9. Source Module Examples
Figure 10. Global Medical-grade Cobalt-60 Revenue by End User, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Medical-grade Cobalt-60 Revenue Market Share by End User in 2025
Figure 12. Source for Gamma Knife Examples
Figure 13. Source for Cobalt Radiotherapy System Examples
Figure 14. Other Examples
Figure 15. Global Medical-grade Cobalt-60 Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Medical-grade Cobalt-60 Revenue Market Share by Application in 2025
Figure 17. Medical Devices Examples
Figure 18. Medical Radiotherapy Examples
Figure 19. Others Examples
Figure 20. Global Medical-grade Cobalt-60 Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 21. Global Medical-grade Cobalt-60 Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 22. Global Medical-grade Cobalt-60 Sales Quantity (2021-2032) & (Curie)
Figure 23. Global Medical-grade Cobalt-60 Price (2021-2032) & (US$/Curie)
Figure 24. Global Medical-grade Cobalt-60 Sales Quantity Market Share by Manufacturer in 2025
Figure 25. Global Medical-grade Cobalt-60 Revenue Market Share by Manufacturer in 2025
Figure 26. Producer Shipments of Medical-grade Cobalt-60 by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 27. Top 3 Medical-grade Cobalt-60 Manufacturer (Revenue) Market Share in 2025
Figure 28. Top 6 Medical-grade Cobalt-60 Manufacturer (Revenue) Market Share in 2025
Figure 29. Global Medical-grade Cobalt-60 Sales Quantity Market Share by Region (2021-2032)
Figure 30. Global Medical-grade Cobalt-60 Consumption Value Market Share by Region (2021-2032)
Figure 31. North America Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 32. Europe Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 33. Asia-Pacific Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 34. South America Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 35. Middle East & Africa Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 36. Global Medical-grade Cobalt-60 Sales Quantity Market Share by Type (2021-2032)
Figure 37. Global Medical-grade Cobalt-60 Consumption Value Market Share by Type (2021-2032)
Figure 38. Global Medical-grade Cobalt-60 Average Price by Type (2021-2032) & (US$/Curie)
Figure 39. Global Medical-grade Cobalt-60 Sales Quantity Market Share by Application (2021-2032)
Figure 40. Global Medical-grade Cobalt-60 Revenue Market Share by Application (2021-2032)
Figure 41. Global Medical-grade Cobalt-60 Average Price by Application (2021-2032) & (US$/Curie)
Figure 42. North America Medical-grade Cobalt-60 Sales Quantity Market Share by Type (2021-2032)
Figure 43. North America Medical-grade Cobalt-60 Sales Quantity Market Share by Application (2021-2032)
Figure 44. North America Medical-grade Cobalt-60 Sales Quantity Market Share by Country (2021-2032)
Figure 45. North America Medical-grade Cobalt-60 Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Medical-grade Cobalt-60 Sales Quantity Market Share by Type (2021-2032)
Figure 50. Europe Medical-grade Cobalt-60 Sales Quantity Market Share by Application (2021-2032)
Figure 51. Europe Medical-grade Cobalt-60 Sales Quantity Market Share by Country (2021-2032)
Figure 52. Europe Medical-grade Cobalt-60 Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 54. France Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Medical-grade Cobalt-60 Sales Quantity Market Share by Region (2021-2032)
Figure 61. Asia-Pacific Medical-grade Cobalt-60 Consumption Value Market Share by Region (2021-2032)
Figure 62. China Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 65. India Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Medical-grade Cobalt-60 Sales Quantity Market Share by Type (2021-2032)
Figure 69. South America Medical-grade Cobalt-60 Sales Quantity Market Share by Application (2021-2032)
Figure 70. South America Medical-grade Cobalt-60 Sales Quantity Market Share by Country (2021-2032)
Figure 71. South America Medical-grade Cobalt-60 Consumption Value Market Share by Country (2021-2032)
Figure 72. Brazil Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 73. Argentina Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 74. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity Market Share by Type (2021-2032)
Figure 75. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity Market Share by Application (2021-2032)
Figure 76. Middle East & Africa Medical-grade Cobalt-60 Sales Quantity Market Share by Country (2021-2032)
Figure 77. Middle East & Africa Medical-grade Cobalt-60 Consumption Value Market Share by Country (2021-2032)
Figure 78. Turkey Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 79. Egypt Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 80. Saudi Arabia Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 81. South Africa Medical-grade Cobalt-60 Consumption Value (2021-2032) & (USD Million)
Figure 82. Medical-grade Cobalt-60 Market Drivers
Figure 83. Medical-grade Cobalt-60 Market Restraints
Figure 84. Medical-grade Cobalt-60 Market Trends
Figure 85. Porters Five Forces Analysis
Figure 86. Manufacturing Cost Structure Analysis of Medical-grade Cobalt-60 in 2025
Figure 87. Manufacturing Process Analysis of Medical-grade Cobalt-60
Figure 88. Medical-grade Cobalt-60 Industrial Chain
Figure 89. Sales Channel: Direct to End-User vs Distributors
Figure 90. Direct Channel Pros & Cons
Figure 91. Indirect Channel Pros & Cons
Figure 92. Methodology
Figure 93. Research Process and Data Source
